Tweet
<img alt="" height="1" width="1" />
Abbott says hepatitis C combo may be a blockbuster
Reuters
NEW YORK, Oct 21 (Reuters) - Abbott Laboratories Inc said on Friday that it could have a shorter duration combination therapy for hepatitis C on the market in 2015 with annual sales potential of about $2 billion. ...
Pharmasset Falls on Rival Abbott Hepatitis C Therapy ResultsBusinessWeek
Abbott says hepatitis C therapy showing early promiseChicago Tribune
Pharmasset Falls on Prospects for Rival Abbott Hepatitis C DrugBloomberg
TheStreet.com -Financial News Network Online -StreetInsider.com (subscription)
all 24 news articles »
More...